Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.
Walk with us. Together, we’ll build lasting value.
We provide emerging biopharma companies with the strategic guidance and resources required to achieve their milestones and fulfill their potential. For growth-oriented biopharmas, we’re a market-maker with the ability to identify and transact target assets and companies across geographies, therapeutic areas, and modalities.
We provide the guidance and resources required for medtech companies to advance to the next level in their growth trajectory—from assessing their first product to building a portfolio to gaining access to public markets.
Overall, a strong understanding of both the biopharma and medtech segments helps our team identify and maximize the potential of convergence opportunities that many innovative life science companies have top-of-mind.
Each quarter we compile key statistics and trends on strategic transactions and financings.
You can download your report here.
Locust Walk has closed high value transactions for multiple clients across a variety of therapeutic areas and modalities. The breadth of our success includes sell-side, buy-side and financing deals. Examples of recent client engagements where Locust Walk served as a transaction advisor are listed below. We would encourage you to click on each case study and/or press release to learn about each assignment in greater detail.